Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Neuraptive Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Neuraptive Therapeutics

Neuraptive Therapeutics

Series A

Neuraptive Therapeutics: A US-based med-tech firm specializing in therapeutic solutions for nerve injuries.

HQ
Lafayette, CO, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Neuraptive Therapeutics, founded with a mission to revolutionize nerve repair, is a US-based medical technology company specializing in therapeutic solutions for peripheral nerve injuries. The company's vision is to develop innovative products that meet the unmet needs of both physicians and patients. Neuraptive offers advanced therapeutic technologies aimed at repairing cut and crushed peripheral nerves, addressing a critical gap in medical treatment.

Notable figures affiliated with Neuraptive include experienced professionals from the biotechnology and medical sectors. The company has garnered attention from investors focused on cutting-edge medical innovations. Key achievements include the development of novel therapeutics and medical products that have shown promise in clinical trials. Neuraptive's impact lies in its potential to significantly improve outcomes for patients suffering from nerve injuries, thereby advancing the field of nerve repair.

Neuraptive Therapeutics - Similar Companies

Renerva logo

Renerva

renerva.com

Neuright logo

Neuright

neurightlabs.com

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Neuraly logo

Neuraly

neuralymed.com

Neurvana Medical logo

Neurvana Medical

Tulavi Therapeutics logo

Tulavi Therapeutics

tulavi.com

Theradaptive logo

Theradaptive

theradaptive.com

Nia Therapeutics logo

Nia Therapeutics

NeuroTherapia logo

NeuroTherapia

neurotherapia.com

Neurana Pharmaceuticals logo

Neurana Pharmaceuticals

neuranapharma.com

NeuRx Medical logo

NeuRx Medical

neurxmed.com

Reservoir Neuroscience logo

Reservoir Neuroscience

reservoirneuro.com

NeuraLace Medical logo

NeuraLace Medical

ReNetX Bio logo

ReNetX Bio

renetx.com

Neurona Therapeutics logo

Neurona Therapeutics

Neuraptive Therapeutics - Quick Facts

Who are Neuraptive Therapeutics' competitors?

Companies similar to Neuraptive Therapeutics include Renerva, Neuright, NeuroTherapeutics Pharma and Neuraly.

When was Neuraptive Therapeutics founded?

Neuraptive Therapeutics was founded in 2016.

Where is Neuraptive Therapeutics' headquarters located?

Neuraptive Therapeutics' headquarters is located in Lafayette, CO, US.

When was Neuraptive Therapeutics' last funding round?

Neuraptive Therapeutics' most recent funding round was for $7.5M (USD) in October 2022.

How much has Neuraptive Therapeutics raised to-date?

As of Oct 25, 2022, Neuraptive Therapeutics has raised a total of $20M (USD).

How many employees does Neuraptive Therapeutics have?

Neuraptive Therapeutics has 18 employees as of Feb 5, 2024.

Neuraptive Therapeutics - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified